Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 15;19(1):20919.
doi: 10.7448/IAS.19.1.20919. eCollection 2016.

HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study

Leila Katirayi  1 , Hazel Namadingo  2 , Mafayo Phiri  2 , Emily A Bobrow  3 , Allan Ahimbisibwe  2 , Aida Yemane Berhan  3 , Nicole Buono  2 , Karen Marie Moland  4 , Thorkild Tylleskär  4
Affiliations

HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study

Leila Katirayi et al. J Int AIDS Soc. .

Abstract

Introduction: The implementation of lifelong antiretroviral treatment (ART) for all pregnant women (Option B+) in Malawi has resulted in a significant increase in the number of HIV-positive pregnant women initiating treatment. However, research has highlighted the challenge of retaining newly initiated women in care. This study explores barriers and facilitators that affect a woman's decision to initiate and to adhere to Option B+.

Methods: A total of 39 in-depth interviews and 16 focus group discussions were conducted. Eligible women were ≥18 years old, living with HIV and either pregnant and receiving antenatal care from a study site or had delivered a child within the last 18 months, breastfed their child and received services at one of the study sites. Eligible women were identified by healthcare workers (HCWs) in the antenatal clinic and ART unit. Focus groups were also conducted with HCWs employed in these departments. Qualitative data were analyzed using Maxqda version 10 (VERBI Software, Berlin, Germany).

Results: The general perception towards the drug regimen used in Option B+ was positive; women reported fewer side effects and acknowledged the positive benefits of ART. Women felt hopeful about prolonging their life and having an HIV-uninfected baby, yet grappled with the fact that ART is a lifelong commitment. Women and HCWs discussed challenges with the counselling services for prevention of mother-to-child HIV transmission under the new Option B+ guidelines, and many women struggled with initiating ART on the same day as learning their HIV status. Women wanted to discuss their circumstances with their husbands first, receive a CD4 count and obtain an HIV test at another facility to confirm their HIV status. HCWs expressed concern that women might just agree to take the drugs to please them. HCWs also discussed concerns around loss to follow-up and drug resistance.

Conclusions: Although Option B+ has significantly increased the number of women initiating ART, there are still challenges that need to be addressed to strengthen initiation, adherence and retention in care. Strategies to strengthen the counselling services upon diagnosis need to be developed to improve same-day initiation of ART and long-term adherence.

Keywords: Option B+; counselling; lifelong HIV treatment; prevention of mother-to-child transmission of HIV; qualitative; same-day initiation.

PubMed Disclaimer

References

    1. Van Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+) J Int AIDS Soc. 2014;17(1):18994. - PMC - PubMed
    1. The World Health Organization (WHO) Implementation of Option B+ for prevention of mother-to-child transmission of HIV: the Malawi experience [Internet] 2014. [cited 2015 Dec 8]. Available from: http://www.zero-hiv.org/wp-content/uploads/2014/04/Implementation-of-Opt....
    1. The Centers for Disease Control and Prevention (CDC) Impact of an innovative approach to prevent mother-to-child transmission of HIV – Malawi, July 2011–September 2012. Morb Mortal Wkly Rep. 2013;62(8):148–51. - PMC - PubMed
    1. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (“Option B+”) in Malawi. AIDS. 2014;28(4):589–98. - PMC - PubMed
    1. Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng'ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Malawi. Trop Med Int Health. 2014;19(11):1360–6. - PubMed

MeSH terms

Substances